We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Micro- and Nanoplastics as Environmental Stressors: Mechanistic Links Among Gut Dysbiosis, Inflammation, and Systemic Health Effects
Summary
This review pulls together existing research on how the tiny plastic particles we're constantly exposed to (in food, water, and air) might harm our health, not just by directly damaging cells, but by disrupting our gut bacteria and triggering chronic inflammation throughout the body. Scientists think this chain reaction could play a role in heart, liver, kidney, lung, and even brain diseases, though the evidence in humans is still early and more research is needed to confirm how serious the risk really is. The takeaway: microplastics may affect health through your gut, not just wherever they physically end up in the body.
Microplastics and nanoplastics (MNPs) have emerged as widespread environmental contaminants, with increasing evidence suggesting that chronic exposure may adversely affect human health. Experimental and emerging human studies indicate that MNPs can interact with multiple biological systems and trigger a range of mechanisms, including oxidative stress, mitochondrial dysfunction, cellular injury, barrier disruption, and immune and inflammatory responses. These effects may involve direct interactions with tissues and cells as well as indirect pathways, including alterations in gut microbial and intestinal homeostasis. In turn, persistent inflammatory and metabolic disturbances may contribute to tissue dysfunction and the development or progression of chronic diseases. This narrative review summarizes current evidence on the biological effects of MNP exposure, focusing on the mechanisms linking environmental exposure to chronic inflammation and disease. We discuss their potential involvement in cardiovascular, liver, kidney, respiratory, and neurological diseases, while highlighting the emerging role of the gut microbiota and intestinal barrier as potential modulators of these effects. Given the limitations of current human evidence and the heterogeneity of experimental models, we also discuss major knowledge gaps and the need for further mechanistic and epidemiological studies to clarify the clinical relevance of chronic MNPs exposure.